General Information of Drug Transporter (DT)
DT ID DTD0001 Transporter Info
Gene Name ABCC1
Protein Name Multidrug resistance-associated protein 1
Gene ID
4363
UniProt ID
P33527
Genetic Polymorphisms of DT (GPD)
Genetic Polymorphism rs119774
Site of GPD chr16:15992976 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP C>T
Minor Allele Frequency T=0.0391/196 (Global)
 Genotype CT Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Montelukast Drug Info Asthma Correlated with the increased changes in FEV1 in patients (compare with genotype CC) [ 1]
Genetic Polymorphism rs4148350
Site of GPD chr16:16076620 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP G>T
Minor Allele Frequency T=0.0681/341 (Global)
 Allele T Click to Show/Hide the Full List of Affected Drugs:            3 Drugs in Total
Daunorubicin Drug Info Neoplasm Irrelevant to the likelihood of cardiotoxicity in patients (compare with allele G) [ 2]
Doxorubicin Drug Info Neoplasm Irrelevant to the likelihood of cardiotoxicity in patients (compare with allele G) [ 2]
Anthracyclines N.A. Neoplasm Correlated with the increased likelihood of cardiotoxicity in patients (compare with allele G) [ 3]
Genetic Polymorphism rs45511401
Site of GPD chr16:16079375 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP G>T
Minor Allele Frequency T=0.0154/77 (Global)
 Allele T Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Doxorubicin Drug Info Non-Hodgkin Lymphoma Correlated with the increased cardiotoxicity risk in patients (compare with allele G) [ 4]
Genetic Polymorphism rs35592
Site of GPD chr16:16047966 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP T>C
Minor Allele Frequency C=0.3704/1855 (Global)
 Allele C Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Methotrexate Drug Info Rheumatoid Arthritis Irrelevant to the drug response in patients (compare with Allele T) [ 5]
 Genotype TT Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Methotrexate Drug Info Psoriasis Correlated with the increased drug response in patients (compare with genotypes CC + CT) [ 6]
Genetic Polymorphism rs17501331
Site of GPD chr16:15995584 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP A>G
Minor Allele Frequency G=0.0383/192 (Global)
 Genotypes AG + GG Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Irinotecan Drug Info Colorectal Neoplasm Correlated with the decreased severity of neutropenia in patients (compare with genotype AA) [ 7]
Genetic Polymorphism rs212091
Site of GPD chr16:16142793 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP T>A / T>C
Minor Allele Frequency C=0.1360/681 (Global)
 Genotypes CC + CT Click to Show/Hide the Full List of Affected Drugs:            4 Drugs in Total
Lamivudine Drug Info HIV Infection Correlated with the increased drug resistance in patients (compare with Genotype TT) [ 8]
Lopinavir Drug Info HIV Infection Correlated with the increased drug resistance in patients (compare with Genotype TT) [ 8]
Zidovudine Drug Info HIV Infection Correlated with the increased drug resistance in patients (compare with Genotype TT) [ 8]
Ritonavir Drug Info HIV Infection Correlated with the increased drug resistance in patients (compare with Genotype TT) [ 8]
Genetic Polymorphism rs2238476
Site of GPD chr16:16120015 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP G>A
Minor Allele Frequency A=0.0691/346 (Global)
 Genotype GG Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Methotrexate Drug Info Psoriasis Correlated with the increased drug response in patients (compare with allele A); Correlated with the increased toxicity risk in patients (compare with genotypes AA + AG) [ 6]
Genetic Polymorphism rs246240
Site of GPD chr16:16025167 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP A>G
Minor Allele Frequency G=0.1827/915 (Global)
 Genotypes AG + GG Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Methotrexate Drug Info Rheumatoid Arthritis Correlated with the decreased drug response in patients (compare with genotype AA) [ 9]
 Genotypes GG + AG Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Methotrexate Drug Info Psoriasis Correlated with the decreased onset of toxicity risk in patients (compare with genotype AA) [ 6]
Genetic Polymorphism rs28364006
Site of GPD chr16:16134392 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP A>G
 Genotype GG Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Methotrexate Drug Info Psoriasis Correlated with the increased drug response in patients (compare with allele AG) [ 6]
Genetic Polymorphism rs35621
Site of GPD chr16:16074751 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP C>T
Minor Allele Frequency T=0.1248/625 (Global)
 Genotypes CT + TT Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Sn-38 Drug Info Colorectal Neoplasm Correlated with the increased drug exposure in patients (compare with genotype CC) [ 7]
Genetic Polymorphism rs3743527
Site of GPD chr16:16141824 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP C>T
Minor Allele Frequency T=0.2943/1474 (Global)
 Genotypes CT + TT Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Irinotecan Drug Info Colorectal Neoplasm Correlated with the decreased severity of neutropenia in patients (compare with genotype CC) [ 7]
Genetic Polymorphism rs3784864
Site of GPD chr16:16031468 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP G>A
Minor Allele Frequency A=0.3271/1638 (Global)
 Genotypes AG + GG Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Methotrexate Drug Info Rheumatoid Arthritis Correlated with the decreased drug response in patients (compare with genotype AA) [ 9]
Genetic Polymorphism rs6498588
Site of GPD chr16:15938949 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP A>T
Minor Allele Frequency A=0.3770/1888 (Global)
 Genotypes AT + TT Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Sn-38 Drug Info Colorectal Neoplasm Correlated with the increased drug exposure in patients (compare with genotype AA) [ 7]
References
1 Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. Am J Respir Crit Care Med. 2006 Feb 15;173(4):379-85.
2 Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children. Pediatr Blood Cancer. 2013 Aug;60(8):1375-81.
3 Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol. 2012 May 1;30(13):1422-8.
4 NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation. 2005 Dec 13;112(24):3754-62.
5 Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis. Sci Rep. 2018 May 9;8(1):7342.
6 Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis. J Invest Dermatol. 2008 Aug;128(8):1925-9.
7 ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia. Pharmacogenomics J. 2018 Jan;18(1):35-42.
8 ABCB1 and ABCC1 variants associated with virological failure of first-line protease inhibitors antiretroviral regimens in Northeast Brazil patients. J Clin Pharmacol. 2013 Dec;53(12):1286-93.
9 Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted? Int J Mol Sci. 2015 Jun 16;16(6):13760-80.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.